ASLAN Pharmaceuticals
Mr. Stephen Doyle is Chief Business Officer at ASLAN Pharmaceuticals. Prior to joining us, Stephen was the Vice President and Head of Specialty Care for China at Boehringer Ingelheim GmbH. Stephen also previously served as the Vice President of Oncology, Hematology and Transplantation Business Unit with Sanofi SA in Shanghai as Regional Commercial Director for Oncology for the Asia Pacific, Russia, and India with Sanofi-Aventis in Singapore, and as Director and Head of Scientific Communications, Global Marketing, Oncology Franchise with Sanofi-Aventis in Paris. Stephen holds an MS in Clinical Pharmacy from the University of Derby in the United Kingdom, and a BS in Pharmacy from The Robert Gordon University in the United Kingdom.
This person is not in any offices
ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.